Harrick Plasma offers benchtop plasma cleaners for surface cleaning and improving wettability of flat substrates and complex surface geometries without affecting the bulk material. Our instruments have been cited in over 3000 publications related to microfluidic, biomedical, and materials research.

Smartphone-controlled design precisely delivers medication.

In lab animals, a particle developed by UCLA, Stanford, NIH scientists awakens dormant virus cells and then knocks them out.

There are multiple applications of nuclear magnetic resonance (NMR) spectroscopy across a variety of industries. This powerful analytical technique has been used to study the structure of molecules, and the interactions between them for the past 60 years. Its broad range of uses in the pharmaceutical, biomedical, food science and many other industries make NMR an invaluable tool. This white paper focuses on a relatively new capability of NMR; monitoring reactions in real-time.

When researchers collected honey samples from around the world, they found that three-quarters of them had a common type of pesticide suspected of playing a role in the decline of bees. Even honey from the island paradise of Tahiti had the chemical.

DNA Damage is ceaseless. The latest in DNA Damage/Genotoxicity Kits, detects seven proteins in this pathway, including important phosphorylation changes. This white paper demonstrates the utility in two cancer cell lines in which all analytes were detected with good specificity, sensitivity and precision.

Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.

This application note explores a robust, simple evaporative sample preparation method that improves the ability to analyze typical levels of these molecules in water samples.

Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes Duchenne muscular dystrophy, a severe muscle-wasting disease.